Shell Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $436K | Buy |
46,451
+17,685
| +61% | +$166K | 0.02% | 526 |
|
|
2025
Q1 | $205K | Sell |
28,766
-1,209
| -4% | -$8.62K | 0.01% | 787 |
|
|
2024
Q4 | $350K | Buy |
29,975
+9,403
| +46% | +$110K | 0.02% | 615 |
|
|
2024
Q3 | $423K | Buy |
+20,572
| New | +$423K | 0.02% | 550 |
|
|
2024
Q1 | $459K | Sell |
20,521
-2,280
| -10% | -$51K | 0.02% | 501 |
|
|
2023
Q4 | $695K | Sell |
22,801
-1,620
| -7% | -$49.4K | 0.03% | 408 |
|
|
2023
Q3 | $772K | Sell |
24,421
-55
| -0.2% | -$1.74K | 0.03% | 415 |
|
|
2023
Q2 | $998K | Buy |
24,476
+22,784
| +1,347% | +$929K | 0.04% | 362 |
|
|
2023
Q1 | $63K | Sell |
1,692
-6
| -0.4% | -$223 | ﹤0.01% | 1164 |
|
|
2022
Q4 | $59K | Sell |
1,698
-344
| -17% | -$12K | ﹤0.01% | 1246 |
|
|
2022
Q3 | $114K | Sell |
2,042
-534
| -21% | -$29.8K | ﹤0.01% | 1184 |
|
|
2022
Q2 | $133K | Buy |
2,576
+4
| +0.2% | +$207 | ﹤0.01% | 1218 |
|
|
2022
Q1 | $187K | Sell |
2,572
-380
| -13% | -$27.6K | ﹤0.01% | 1176 |
|
|
2021
Q4 | $349K | Buy |
2,952
+17
| +0.6% | +$2.01K | 0.01% | 1057 |
|
|
2021
Q3 | $394K | Buy |
+2,935
| New | +$394K | 0.01% | 972 |
|